Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017101
University of California Sys Office/Pres, Oakland, CA, United States
Search grants from University of California Sys Office/Pres
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Integration of Iso and Quality Management System Standards Into National Public H
Recombinant Growth Hormone and Chronic Renal Insufficiency
Regulation of Fibrinogen Synthesis - Role of Hsf/Ifn B2
Neural Control of Physiological Systems
U.S.-Australia Cooperative Research: Analysis of the Food Foraging Behavior of Apple Maggot and Queensland Fruit Flies
Recently added grants:
The role of PCDH7 in lung cancer pathogenesis
Imaging of nanotherapeutic drug action
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
Developing Nano Technology for HER2 Directed Therapy
Advancing Clinical Research Training within Addiction Residency Programs
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017101-002
Application #
6688650
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of California Sys Office/Pres
Department
Type
DUNS #
003985512
City
Oakland
State
CA
Country
United States
Zip Code
94607
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
Comments
Be the first to comment on this grant